In vitro effects of budesonide on eosinophil-basophil lineage commitment.
about
The In Vivo Granulopoietic Response to Dexamethasone Injection Is Abolished in Perforin-Deficient Mutant Mice and Corrected by Lymphocyte Transfer from Nonsensitized Wild-Type Donors.Odd couple: The unexpected partnership of glucocorticoid hormones and cysteinyl-leukotrienes in the extrinsic regulation of murine bone-marrow eosinopoiesis.CSL311, a novel, potent, therapeutic monoclonal antibody for the treatment of diseases mediated by the common β chain of the IL-3, GM-CSF and IL-5 receptorsMolecular and clinical rationale for therapeutic targeting of interleukin-5 and its receptor.Toll-like receptor-induced expression of epithelial cytokine receptors on haemopoietic progenitors is altered in allergic asthma.
P2860
In vitro effects of budesonide on eosinophil-basophil lineage commitment.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
In vitro effects of budesonide on eosinophil-basophil lineage commitment.
@en
In vitro effects of budesonide on eosinophil-basophil lineage commitment.
@nl
type
label
In vitro effects of budesonide on eosinophil-basophil lineage commitment.
@en
In vitro effects of budesonide on eosinophil-basophil lineage commitment.
@nl
prefLabel
In vitro effects of budesonide on eosinophil-basophil lineage commitment.
@en
In vitro effects of budesonide on eosinophil-basophil lineage commitment.
@nl
P2093
P2860
P1476
In vitro effects of budesonide on eosinophil-basophil lineage commitment.
@en
P2093
Adrian J Baatjes
Judah A Denburg
Lynn Crawford
Michael M Cyr
Paul O' Byrne
Rafeul Alam
Roma Sehmi
Ronan Foley
Sandra C Dorman
P2860
P356
10.2174/1874306400802010060
P577
2008-06-13T00:00:00Z